🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchPhase 3 trial enrollment guide — my results so far Page 3

Phase 3 trial enrollment guide — my results so far

josh_phd_bmore Mon, Feb 23, 2026 at 12:22 PM 21 replies 1,019 viewsPage 3 of 5
JennaRN
Senior Member
1,987
8,923
Mar 2024
Colorado
Online
Feb 26, 2026 at 3:24 AM#11
BariatricNurseD said:
Propensity score matching studies and the trial evidence: when RCTs aren't available for a specific question, propensity score-matched observational…

Fair, and it stops being fair at the extremes. The middle of the range is well understood; the ends are where the honest answer is that nobody knows.

31 6Dr.KarenChen, Dr.NateNeph, PharmD_Rodriguez and 28 others
Reply Quote Save Share Report
andrew_nyc
Member
534
2,345
Apr 2024
New York, NY
Feb 26, 2026 at 10:25 AM#12
rachel_ABQ said:
Dr.GutHealth said: ...regarding the trial evidence...

Thank you for spelling out the reasoning rather than just the conclusion. Sending this to two other people who asked me the same thing last week.

Last edited: Feb 26, 2026 at 3:25 PM
30 5Dr.NateNeph, PharmD_Rodriguez, julia.endo and 27 others
Reply Quote Save Share Report
RickReta_CO
Member
312
1,234
Jan 2025
Colorado
Feb 26, 2026 at 5:27 PM#13
BariatricNurseD said:
Propensity score matching studies and the trial evidence: when RCTs aren't available for a specific question, propensity score-matched observational…

I read this differently. The confidence in this thread is running ahead of the evidence, and I would rather the uncertainty were stated than smoothed over because it is unsatisfying.

29 4hyun_seoul, jim_asheville, matt_MKE and 26 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
PeptideSynthNJ
Member
234
1,234
Aug 2024
Princeton, NJ
Feb 27, 2026 at 12:29 AM#14

One concrete data point for the thread. Practical: whatever you change, write down the date and the reason. In three months the reason is what you will have forgotten, and the reason is what makes the record worth having.

28 3MikeKY_noInsulin, Dr.RaviCardio, jennifer_SEA and 25 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Feb 27, 2026 at 7:31 AM#15

Moderator note: good thread. Keeping it here rather than moving it, because the question is general enough to be useful.

Last edited: Feb 27, 2026 at 11:31 AM
27 2PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 24 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register